Evidence map›Paper›PMID 32708433›Full record

ArticleInternational journal of molecular sciences2020

Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis.

Ying-Ming Tsai, Kuan-Li Wu, Yung-Yun Chang, Wei-An Chang, Yung-Chi Huang, Shu-Fang Jian, Pei-Hsun Tsai, Yi-Shiuan Lin, Inn-Wen Chong, Jen-Yu Hung and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects.Cellular and molecular life sciences : CMLS · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ying-Ming TsaiGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Kuan-Li WuGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Yung-Yun ChangDepartment of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Wei-An ChangDepartment of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Yung-Chi HuangGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Shu-Fang JianGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Pei-Hsun TsaiGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Yi-Shiuan LinGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Inn-Wen ChongGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Jen-Yu HungGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Ya-Ling HsuGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Kaohsiung Medical University · TWKaohsiung Medical University Chung-Ho Memorial Hospital · TW

Funding

Kaohsiung Medical University Research Funding, Taiwan KMU-Q108006, KMU-DK 105002; KMU-DK108003; KMU-DK108008; KMU-TC108A03-5Kaohsiung Municipal Ta-Tung Hospital, Taiwan KMTTH-103-019; KMTTH-105-051Ministry of Science and Technology, Taiwan MOST107-2314-B-037-107-MY3; MOST 108-2320-B-037-024 -MY3; MOST 108-2314-B-037-094-; MOST 108-2314-B-037-095-; 107-2314-B-037-107-MY3
6 · The paper itself

Abstract

For decades, lung cancer has been the leading cause of cancer-related death worldwide. Hypoxia-inducible factors (HIFs) play critical roles in mediating lung cancer development and metastasis. The present study aims to clarify how HIF's over-activation affects lung cancer angiogenesis not only in a normoxic condition, but also a hypoxic niche. Our study shows that human lung cancer exhibits elevated levels of ceruloplasmin (CP), which has a negative impact on the prognosis of patients. CP affects the cellular Fe

Indexed as

Adenocarcinoma of LungBasic Helix-Loop-Helix ProteinsCell HypoxiaCell Line, TumorCell MovementCell ProliferationCeruloplasminEndothelial PAS Domain-Containing Protein 1Gene Expression Regulation, NeoplasticHumansIronLung NeoplasmsMicroRNAsNeovascularization, PathologicPrognosisProlyl HydroxylasesBasic Helix-Loop-Helix ProteinsCeruloplasminEndothelial PAS Domain-Containing Protein 1IronMicroRNAsMIRN145 microRNA, humanProlyl HydroxylasesVascular Endothelial Growth Factor AVEGFA protein, humanangiogenesisceruloplasminHIF-2αlung cancermiR-145-5p

Identifiers

PMID32708433
PMCPMC7404111
OpenAlexW3043751685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.